Clover Corporation (ASX:CLV) sees 23.6pc profit growth in FY20
Microencapsulation technology company Clover Corporation (CLV) has seen a 23.6 per cent…
Clover Corporation Limited (ASX:CLV)
$1.68
0.02 (1.2%)
MCAP $279.6M
Last trade
16.10pm 19/01/2022
20mins delayed
Latest Announcements
13/01/2022CLVClover Corporation Limited
126
MCap
13/12/2021CLVClover Corporation Limited
240
MCap
18/11/2021CLVClover Corporation Limited
18/11/2021CLVClover Corporation Limited
18/11/2021 Price SensitivePSCLVClover Corporation Limited
18/11/2021 Price SensitivePSCLVClover Corporation Limited
161
MCap
17/11/2021CLVClover Corporation Limited
163
MCap
28/10/2021CLVClover Corporation Limited
Company Overview
Clover Corporation Limited is an Australia-based company, which is engaged in the refining and sale of natural oil. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The Company is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. It focuses on developing nutrients for use in foods or as nutritional supplements. The Company provides lipid-based ingredients for the food industry. It focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. It uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. It has a technology license for the encapsulation of marine and algal oils. The Company has a manufacturing plant for tuna oils and related products in Altona, Victoria.
